bf/NASDAQ:SRPT_icon.jpeg

COM:SAREPTA

Sarepta Therapeutics

  • Stock

Last Close

110.50

22/11 21:00

Market Cap

14.11B

Beta: -

Volume Today

872.57K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
3.63M
-
20.36M
461.59%
30.17M
48.20%
19.84M
34.23%
48.21M
142.95%
104.53M
116.82%
148.41M
41.99%
201.67M
35.89%
209.09M
3.68%
195.09M
6.69%
263.41M
35.02%
average payables
12.58M
-
15.02M
19.38%
16.32M
8.65%
24.96M
52.94%
19.08M
23.57%
21.15M
10.85%
50.96M
140.98%
89.59M
75.80%
93.92M
4.83%
86.31M
8.10%
130.40M
51.08%
average receivables
4.12M
-
2.97M
27.87%
3.20M
7.52%
4.60M
43.99%
17.35M
276.93%
39.26M
126.29%
71.49M
82.11%
116.26M
62.62%
155.11M
33.42%
215.67M
39.04%
330.01M
53.02%
book value per share
7.30
-
6.19
15.27%
4.50
27.25%
6.91
53.61%
13.42
94.07%
15.58
16.12%
11.11
28.67%
9.77
12.08%
11.42
16.87%
4.74
58.52%
capex per share
-0.11
-
-0.67
500.95%
-0.11
82.95%
-0.14
23.37%
-0.36
155.82%
-0.97
169.28%
-0.85
12.29%
-1.05
23.78%
-0.47
55.08%
-0.38
19.92%
capex to depreciation
-2.96
-
-7.27
145.92%
-0.92
87.33%
-1.22
32.85%
-2.62
114.25%
-5.25
100.43%
-2.05
60.93%
-3.05
48.79%
-1.01
66.86%
-0.74
27.28%
-1.71
132.82%
capex to operating cash flow
0.06
-
0.21
257.65%
0.03
84.51%
0.03
13.62%
0.09
227.40%
0.17
81.04%
0.14
17.01%
-0.76
656.75%
0.09
111.35%
0.09
9.09%
0.15
60.34%
capex to revenue
-0.27
-
-2.75
935.56%
-3.86
40.30%
-1.27
67.16%
-0.14
89.16%
-0.21
55.75%
-0.16
22.96%
-0.15
7.58%
-0.05
63.97%
-0.03
39.76%
-0.06
85.28%
cash per share
7.59
-
5.26
30.77%
4.55
13.39%
6.53
43.40%
18.35
181.07%
17.72
3.41%
15.28
13.77%
24.87
62.76%
26.04
4.71%
24.48
5.98%
days of inventory on hand
29.31
-
35.97K
-
4.15K
88.46%
1.34K
67.73%
1.11K
17.45%
1.34K
20.84%
700.34
47.57%
531.82
24.06%
783.83
47.39%
days payables outstanding
71.29
-
83.36K
-
420.30
99.50%
361.11
14.08%
439.23
21.63%
639.74
45.65%
288.62
54.88%
249.98
13.39%
400.38
60.17%
days sales outstanding
90.61
-
90.38
0.26%
1.16K
1,181.81%
352.01
69.62%
69.58
80.23%
59.47
14.54%
90.03
51.40%
93.65
4.02%
89.26
4.70%
101.59
13.82%
117.52
15.68%
debt to assets
0.01
-
0.02
274.92%
0.09
298.45%
0.04
55.44%
0.33
765.43%
0.34
2.49%
0.40
18.50%
0.42
6.00%
0.45
5.57%
0.52
15.42%
0.43
17.24%
debt to equity
0.01
-
0.03
278.67%
0.12
381.07%
0.05
60.98%
0.55
1,038.65%
0.54
1.62%
0.89
65.97%
1.66
86.43%
1.52
8.60%
4.20
176.51%
1.63
61.31%
dividend yield
earnings yield
-0.16
-
-0.23
44.36%
-0.13
42.48%
-0.20
48.37%
-0.02
92.26%
-0.05
223.20%
-0.08
50.38%
-0.04
44.61%
-0.06
37.26%
-0.07
16.74%
enterprise value
434.23M
-
511.95M
17.90%
1.57B
207.58%
1.23B
21.92%
3.10B
152.46%
7.28B
134.52%
9.39B
29.04%
12.86B
36.91%
6.34B
50.70%
11.18B
76.34%
968.38M
91.34%
enterprise value over ebitda
-6.36
-
-3.91
38.57%
-7.15
83.01%
-4.61
35.55%
-13.00
182.07%
-21.24
63.34%
-20.01
5.78%
-24.30
21.43%
-15.38
36.69%
-23.61
53.47%
-3.62
84.69%
ev to operating cash flow
-6.71
-
-3.98
40.66%
-10.54
164.51%
-5.00
52.53%
-13.38
167.51%
-18.73
39.99%
-20.58
9.88%
119.67
681.52%
-14.31
111.95%
-34.36
140.21%
-1.93
94.38%
ev to sales
30.54
-
52.47
71.82%
1.26K
2,295.06%
226.80
81.95%
20.08
91.15%
24.18
20.43%
24.67
2.00%
23.81
3.46%
9.03
62.07%
11.98
32.66%
0.78
93.50%
free cash flow per share
-2.02
-
-3.88
91.90%
-3.65
6.00%
-5.19
42.22%
-4.30
17.04%
-6.84
58.83%
-7.05
3.14%
0.32
104.60%
-5.93
1,928.95%
-4.38
26.05%
free cash flow yield
-0.10
-
-0.27
170.14%
-0.09
64.75%
-0.19
100.03%
-0.08
59.10%
-0.06
19.02%
-0.05
12.77%
0.00
103.48%
-0.07
3,562.72%
-0.03
48.61%
graham net net
6.47
-
4.53
29.86%
2.97
34.57%
4.94
66.63%
10.61
114.66%
10.02
5.61%
3.75
62.54%
-0.83
122.04%
1.45
275.19%
-5.63
488.39%
graham number
23.31
-
21.73
6.79%
22.95
5.62%
29.22
27.29%
16.13
44.80%
43.76
171.32%
49.29
12.62%
39.53
19.79%
36.39
7.95%
30.38
16.52%
income quality
0.58
-
0.95
63.85%
0.68
28.24%
0.92
35.40%
4.58
397.62%
1.07
76.54%
0.64
40.56%
-0.19
130.38%
1.06
645.66%
0.46
56.30%
0.93
102.11%
intangibles to total assets
0.02
-
0.02
15.47%
0.02
21.50%
0.02
21.51%
0.01
42.37%
0.01
35.78%
0.01
2.73%
0.00
33.40%
0.00
0.94%
0.00
46.45%
0
100%
interest coverage
-276.94
-
498.56
-
-29.69
105.96%
-10.19
65.67%
-17.03
67.07%
-9.41
44.74%
-7.08
24.78%
-10.07
42.24%
interest debt per share
0.06
-
0.16
168.38%
0.55
249.96%
0.32
42.04%
7.43
2,216.14%
8.88
19.58%
10.33
16.29%
17.01
64.74%
18.13
6.58%
20.56
13.37%
inventory turnover
12.45
-
0.01
-
0.09
766.84%
0.27
209.92%
0.33
21.13%
0.27
17.24%
0.52
90.74%
0.69
31.69%
0.47
32.15%
invested capital
0.01
-
0.03
278.67%
0.12
381.07%
0.05
60.98%
0.55
1,038.65%
0.54
1.62%
0.89
65.97%
1.66
86.43%
1.52
8.60%
4.20
176.51%
1.63
61.31%
market cap
689.52M
-
579.18M
16.00%
1.63B
181.70%
1.34B
18.13%
3.27B
145.00%
7.23B
120.92%
9.50B
31.39%
13.29B
39.91%
7.32B
44.94%
10.53B
43.90%
net current asset value
226.43M
-
200.42M
11.49%
141.11M
29.59%
286.06M
102.73%
709.90M
148.16%
816.38M
15.00%
464.28M
43.13%
262.24M
43.52%
384.13M
46.48%
-185.56M
148.30%
174.09M
193.82%
net debt to ebitda
3.74
-
0.51
86.28%
0.26
49.63%
0.40
54.16%
0.71
77.30%
-0.15
120.54%
0.22
254.86%
0.81
261.45%
2.37
192.09%
-1.37
157.92%
-3.62
163.18%
net income per share
-3.31
-
-3.39
2.55%
-5.20
53.36%
-5.49
5.49%
-0.86
84.30%
-5.46
533.91%
-9.71
77.81%
-7.11
26.82%
-5.15
27.50%
-8.66
67.99%
operating cash flow per share
-1.91
-
-3.21
68.03%
-3.53
10.05%
-5.05
42.83%
-3.94
21.86%
-5.87
48.74%
-6.20
5.70%
1.38
122.23%
-5.45
495.61%
-4.00
26.59%
payables turnover
5.12
-
0.00
-
0.87
19,733.61%
1.01
16.39%
0.83
17.78%
0.57
31.34%
1.26
121.65%
1.46
15.46%
0.91
37.57%
receivables turnover
4.03
-
4.04
0.26%
0.32
92.20%
1.04
229.12%
5.25
405.91%
6.14
17.01%
4.05
33.95%
3.90
3.87%
4.09
4.93%
3.59
12.15%
3.11
13.55%
research and ddevelopement to revenue
5.13
-
9.66
88.35%
116.83
1,109.75%
34.73
70.27%
1.08
96.89%
1.33
23.78%
1.47
10.34%
1.34
9.19%
1.10
17.85%
0.94
14.44%
0.71
24.93%
return on tangible assets
-0.39
-
-0.47
20.16%
-0.82
75.38%
-0.64
22.00%
-0.04
93.90%
-0.22
466.48%
-0.39
77.95%
-0.19
52.78%
-0.13
28.35%
-0.23
68.68%
-0.16
27.17%
revenue per share
0.42
-
0.24
41.97%
0.03
87.85%
0.11
275.72%
2.63
2,260.90%
4.54
72.89%
5.17
13.85%
6.93
33.92%
8.64
24.67%
11.48
32.93%
roe
-0.45
-
-0.55
21.03%
-1.16
110.82%
-0.79
31.33%
-0.06
91.91%
-0.35
445.89%
-0.87
149.28%
-0.73
16.77%
-0.45
37.96%
-1.83
304.97%
-0.62
65.87%
roic
-0.43
-
-0.52
21.27%
-1.01
93.30%
-0.73
26.97%
-0.15
80.04%
-0.22
47.41%
-0.33
51.73%
-0.27
18.25%
-0.19
29.53%
-0.26
39.45%
-0.11
56.61%
sales general and administrative to revenue
2.22
-
5.05
127.47%
59.89
1,084.94%
14.98
74.99%
0.78
94.82%
0.70
10.03%
0.75
7.21%
0.59
21.30%
0.40
31.58%
0.48
20.14%
shareholders equity per share
7.30
-
6.19
15.27%
4.50
27.25%
6.91
53.61%
13.42
94.07%
15.58
16.12%
11.11
28.67%
9.77
12.08%
11.42
16.87%
4.74
58.52%
stock based compensation to revenue
0.78
-
2.09
166.46%
25.63
1,129.26%
5.53
78.44%
0.20
96.43%
0.17
15.51%
0.21
23.95%
0.20
3.05%
0.16
18.87%
0.25
53.84%
0.15
41.22%
tangible asset value
242.15M
-
241.76M
0.16%
183.71M
24.01%
328.62M
78.88%
774.86M
135.80%
1.02B
31.73%
805.69M
21.07%
748.13M
7.14%
913.77M
22.14%
377.37M
58.70%
859.34M
127.72%
tangible book value per share
7.15
-
6.04
15.57%
4.34
28.08%
6.75
55.35%
13.17
95.22%
15.41
16.95%
10.94
28.96%
9.60
12.31%
11.24
17.17%
4.64
58.70%
working capital
234.84M
-
210.93M
10.18%
162.25M
23.08%
298.05M
83.70%
1.14B
282.59%
1.25B
9.84%
1.20B
3.86%
2.07B
71.84%
2.15B
3.97%
1.94B
9.91%
1.93B
0.65%

All numbers in (except ratios and percentages)